The Alliance for Clinical Trials in Oncology Foundation is a nonprofit, tax-exempt 501(c)(3) organization based in Chicago, Illinois, founded in 1993. Also known as the Cancer and Leukemia Group B Foundation (CALGB Foundation), the organization raises funds to support the Alliance for Clinical Trials in Oncology in conducting large-scale clinical trials. The Alliance itself is a National Clinical Trials Network (NCTN) sponsored by the National Cancer Institute (NCI), consisting of nearly 10,000 cancer specialists at hospitals, medical centers, and community clinics across the United States and Canada.
Financial Overview
From 2024 IRS Form 990-PF · View filing
Total Assets
$112.8M
-4.5% YoY
Annual Giving
$12.8M
+41.1% YoY
Grant Count
109
+28.2% YoY
Avg Grant Size
$117K
+10.0% YoY
Mission & Focus Areas
The Alliance's three-fold mission is to:
- Conduct high-quality multidisciplinary cancer control, prevention, and treatment trials that engage a comprehensive research network
- Further understanding of the biological basis of the cancer process and its treatment, from discovery to validation to clinical practice
- Reduce the impact of cancer on people by uniting a broad community of scientists and clinicians from many disciplines committed to discovering, validating, and disseminating effective strategies for prevention and treatment of cancer
The foundation supports research in:
- New chemotherapy treatments for breast, prostate, lung, and colorectal cancer
- Surgical techniques for breast and colon cancer
- Genetic studies of breast cancer risk
- Molecular determinants of cancer therapy response
- Research improving cancer patients' quality of life and alleviating side effects of cancer and cancer treatments
Grantmaking
The Alliance for Clinical Trials in Oncology Foundation distributes grants through several program areas:
Grant Range
$15,000 to $200,000+ per award
Grant Types
How to Apply
**
Ready to take the next step with Alliance for Clinical Trials in Oncology?
Geographic Focus
Where this funder awards grants
The foundation focuses on funding Alliance member institutions in the United States and Canada.
Grant Distribution by State
States
Cities
Financial History
Multi-year comparison from IRS filings
As of 2024:
- Total assets: $112,814,085
- Total revenues: $44,527,686
- Total expenses: $48,256,468
- Total giving: $14,639,183
As of 2023:
- Annual giving: $10,308,272
- Number of awards: 86
| Metric | 2024 | 2023 | 2022 |
|---|---|---|---|
| Total Assets | $112,814,085 | $118,132,432 | $121,663,797 |
| Revenue | $44,527,686 | $41,500,086 | $39,386,118 |
| Expenses | $48,256,468 | $40,022,855 | $42,878,871 |
| Qualifying Distributions | — | — | — |
| Net Investment Income | $5,272,539 | $3,440,233 | $3,415,730 |
| Distributable Amount | — | — | — |
Giving Over Time
Total grant dollars and number of grants per year
Grant Insights
How this funder distributes its grants
Top Recipients
Top 10 recipients in 2024
Grant Size Distribution
250 grants across all recorded years
Giving History
Grant recipients and amounts by year
Among its reported 2024 grants, the largest include Mayo Clinic ($1,962,448), Alliance Nctn Foundation ($922,160), The Ohio State University ($764,553).
| Recipient | Purpose | Amount |
|---|---|---|
| MAYO CLINIC ROCHESTER, MN | CANCER RESEARCH | $1,962,448 |
| ALLIANCE NCTN FOUNDATION CHICAGO, IL | GENERAL OPERATING SUPPORT | $922,160 |
| THE OHIO STATE UNIVERSITY COLUMBUS, OH | CANCER RESEARCH | $764,553 |
| UNIVERSITY OF CINCINNATI CANCER CENTER CINCINNATI, OH | CANCER RESEARCH | $736,549 |
| ECOG-ACRIN MEDICAL RESEARCH FOUNDATION INC PHILADELPHIA, PA | CANCER RESEARCH | $637,733 |
| NRG ONCOLOGY FOUNDATION INC PHILADELPHIA, PA | CANCER RESEARCH | $579,938 |
| DANA-FARBER CANCER INSTITUTE INC BOSTON, MA | CANCER RESEARCH | $531,176 |
| DUKE UNIVERSITY DURHAM, NC | CANCER RESEARCH | $498,422 |
| ADAPTIVE BIOTECHNOLOGIES SEATTLE, WA | CANCER RESEARCH | $494,055 |
| WASHINGTON UNIVERSITY ST LOUIS, MO | CANCER RESEARCH | $470,561 |
Leadership & Key People
Officers and directors from IRS filings
Compensation Overview
From 2024 IRS filing
From 2024 filing
| Name | Title | Hours | Compensation |
|---|---|---|---|
| DHRUVA GOLLERKERI | TREASURER/CFO | 30 | $254,042 |
| EVANTHIA GALANIS | PRESIDENT | 0.75 | — |
| KIMBERLY KERSTANN CHIEF OPE- | RATING OFFICER & SECRETARY | 9 | $75,094 |
| TRINIDAD AJAZI | SECRETARY (THRU JUN 2024) | 9 | — |
| OLWEN HAHN | VICE PRESIDENT/TRUSTEE | 0.75 | — |
| TAREQ AL BAGHDADI | TRUSTEE | 0.75 | — |
| STEVEN ALBERTS | TRUSTEE | 0.75 | — |
| DANIEL ANDERSON | TRUSTEE | 0.75 | — |
| C BABIS ANDREADIS | TRUSTEE | 0.75 | — |
| LYUDMILA BAZHENOVA | TRUSTEE | 0.75 | — |
| ISABELLE BEDROSIAN | TRUSTEE | 0.75 | — |
| HAROLD BURSTEIN | TRUSTEE | 0.75 | — |
| LISA CAREY | TRUSTEE | 0.75 | — |
| JEFFREY CRAWFORD | TRUSTEE | 0.75 | — |
| MARCIA CRUZ-CORREA | TRUSTEE | 0.75 | — |
| KONSTANTIN DRAGNEV | TRUSTEE | 0.75 | — |
| JOHN ELLERTON | TRUSTEE | 0.75 | — |
| BRYAN FALLER | TRUSTEE | 0.75 | — |
| GINI FLEMING | TRUSTEE | 0.75 | — |
| RICHARD GOLDBERG | TRUSTEE | 0.75 | — |
| STEPHEN GRAZIANO | TRUSTEE | 0.75 | — |
| STEPHEN GRUBBS | TRUSTEE | 0.75 | — |
| CAROLYN HENDRICKS | TRUSTEE | 0.75 | — |
| CLIFFORD HUDIS | TRUSTEE | 0.75 | — |
| KELLY HUNT | TRUSTEE | 0.75 | — |
| HEIDI KLEPIN | TRUSTEE | 0.75 | — |
| JOHN LEONARD | TRUSTEE | 0.75 | — |
| ELLIS LEVINE | TRUSTEE | 0.75 | — |
| SUMITHRA MANDREKAR | TRUSTEE | 0.75 | — |
| GREGORY MASTERS | TRUSTEE | 0.75 | — |
| ELECTRA PASKETT | TRUSTEE | 0.75 | — |
| JANE PERLMUTTER | TRUSTEE | 0.75 | — |
| STEVEN PIANTADOSI | TRUSTEE | 0.75 | — |
| DEBORAH SCHRAG | TRUSTEE | 0.75 | — |
| MICHAEL SCHWARTZ | TRUSTEE | 0.75 | — |
| W FRASER SYMMANS | TRUSTEE | 0.75 | — |
| MARIE WOOD | TRUSTEE | 0.75 | — |
| CARTER W DUFRANE | DIRECTOR OF CLINICAL TRIAL OPS | 40 | $245,377 |
| MAJAGAMY RAMOS-BORDONARO | DIRECTOR, QUALITY MANAGEMENT | 40 | $198,090 |
| LISA RENEE PITLER | SENIOR DIRECTOR, COMPLIANCE & HR | 30 | $236,259 |
| SELINA CHOW | EXECUTIVE OFFICER | 20 | $254,427 |
| JOSEPH GANNON | SR. PROJECT MANAGER | 40 | $198,234 |
| AISHA AHMED DIRECTOR | COLLABORATIONS AND TRIAL MGMT | 40 | $211,604 |
Recent News & Activity
Recent developments and announcements
The Alliance for Clinical Trials in Oncology Foundation has announced several funding award programs, including:
Six Investigators Win Funding Awards - Alliance -**Robert A. Winn Excellence in Clinical Trials Award Program**: Announced a third cohort of physician researchers for the Clinical Investigator Leadership Award
Six Investigators Win Funding Awards - Alliance -**Alliance Scholar Awards**: Funding opportunities for emerging investigators
Six Investigators Win Funding Awards - Alliance -**Cancer Control and Prevention (CCP) and Cancer Control and Detection Research (CCDR) Awards**: Investigator funding awards
Six Investigators Win Funding Awards - Alliance -**Biomarkers, Imaging, and Quality of Life Studies Funding Program (BIQSFP)**: Funding opportunity announced in March 2022
Six Investigators Win Funding Awards - Alliance -The organization maintains tax-exempt status since September 1994 and has received a Three-Star rating from Charity Navigator, indicating solid performance in accountability and finance.
Subject Areas
Focus areas based on grantmaking activity
Frequently Asked Questions
What does Alliance for Clinical Trials in Oncology fund?
The Alliance's three-fold mission is to: 1. Conduct high-quality multidisciplinary cancer control, prevention, and treatment trials that engage a comprehensive research network 2. Further understanding of the biological basis of the cancer process and its treatment, from discovery to validation to clinical practice 3. Reduce the impact of cancer on people by uniting a broad community of scientists and clinicians from many disciplines committed to discovering, validating, and disseminating effec…
How do I apply for a grant from Alliance for Clinical Trials in Oncology?
The Alliance for Clinical Trials in Oncology Foundation distributes grants through several program areas: **Grant Types:** • **Ancillary Project Grants**: Support for expenses of multidisciplinary companion studies and Alliance treatment studies relating to cancer research • **Statistical and Data Management Grants**: Support for costs incurred to develop clinical trials, collect patient data from institutions, and analyze data for publication of study results • **Alliance Foundation Trials**: …
Where does Alliance for Clinical Trials in Oncology make grants?
The foundation focuses on funding Alliance member institutions in the United States and Canada.
What size grants does Alliance for Clinical Trials in Oncology award?
In 2024, Alliance for Clinical Trials in Oncology awarded 109 grants totaling $12.8M — an average of about $117K per grant, based on its IRS Form 990 filings.
What is Alliance for Clinical Trials in Oncology's EIN?
Alliance for Clinical Trials in Oncology's EIN (Employer Identification Number) is 02-0464400. IRS Form 990 filing data is available on this page for 2020–2024.
Explore Open Grants
Browse active grant opportunities in Alliance for Clinical Trials in Oncology's focus areas in our free grants database
Similar Funders
Funders that support many of the same organizations
American Cancer Society Inc
ATLANTA, GA
Assets
$1.7B
Grants
688
Total Given
$197.1M
American Heart Association Inc
DALLAS, TX
Assets
$1.9B
Grants
794
Total Given
$227.6M
Mayo Clinic
ROCHESTER, MN
Assets
$26.7B
Grants
256
Total Given
$572.1M
Yale University
NEW HAVEN, CT
Assets
$55.2B
Grants
344
Total Given
$137.2M
Emory University
ATLANTA, GA
Assets
$22.2B
Grants
352
Total Given
$240.1M
Johns Hopkins University
BALTIMORE, MD
Assets
$23.0B
Grants
757
Total Given
$467.3M
Alliance Nctn Foundation
CHICAGO, IL
Assets
$4.5M
Grants
70
Total Given
$3.6M
Vanguard Charitable Endowment Program
SOUTHEASTERN, PA
Assets
$22.2B
Grants
24,269
Total Given
$3.0B
Vanderbilt University Medical Center
NASHVILLE, TN
Assets
$6.6B
Grants
234
Total Given
$112.3M
National Philanthropic Trust
JENKINTOWN, PA
Assets
$42.2B
Grants
18,583
Total Given
$5.1B
Mayo Clinic Group Return
ROCHESTER, MN
Assets
$17.9B
Grants
293
Total Given
$1.7B
The Children's Oncology Group
PHILADELPHIA, PA
Assets
$21.4M
Grants
56
Total Given
$911K
Data last updated June 2026. Sourced from IRS Form 990-PF filings. Research dossier generated April 2026.
What could you do with Alliance for Clinical Trials in Oncology on Grantable?
- Assess strategic fit with your organization
- Draft a tailored letter of inquiry
- Find open RFPs from this funder
- Monitor for new funding opportunities
Go from researching Alliance for Clinical Trials in Oncology to a real strategy.